SlideShare a Scribd company logo
2
Most read
3
Most read
17
Most read
FIXED DOSE COMBINATION
BY: PRIYA NIGAM
M.Sc. Clinical Research
DEFINITION OF FDC
The combination of two different drugs in a single pharmaceutical
formulation is known as fixed drug dose combination. Medicines are an integral
part of healthcare. More than one drug is frequently used for treatment of
either single ailment or multiple comorbid conditions. Sometimes, two or more
drugs are combined in a fixed ratio into a single dosage form, which is termed
as fixed dose combinations (FDCs). The FDCs are justified when they
demonstrate clear benefits in terms of (a) potentiating the therapeutic efficacy,
(b) reducing the incidence of adverse effect of drugs, (c) having
pharmacokinetic advantage.
Safety and efficacy
• There is little question that many patients benefit from receiving more than one
pharmaceutical active to treat a medical condition when their actions are synergistic, or at
least additive.
• Often, efficacy can be significantly improved with minimal impact on the combination
product’s safety and tolerability.
• The combination of a beta-blocker with a diuretic has a well-established safety and efficacy
profile as an antihypertensive.
• Raise the dose of the beta-blocker, and you start to have tolerability and safety issues, yet the
diuretic alone has limited efficacy by itself.
• Put them together, and you have a much better balance of efficacy and safety.
AS A RULE
• Two drugs to be combined have approxiamately equal plasma half life
• The ratio of doses of each component should depend on apparent volume
of distribution and plasma concentration.
• EXAMPLE:
• Amoxycillin(t½ -1-2hr, Vd-0.21L/kg) hence clavulanic acid(t½-1-1.5hr, Vd-
0.2L/kg) hence these can be combined in their standard dose
regimen.. i.e amoxycillin 500mg +clavulanic acid 125mg can be
administered as 1 to 2 tablet 8 hourly
MERITS
 Convenience in dose schedule and better patients compiliance.
 Enchanced effect of the combination
e.g-oestrogen+progestrogene
 Minimisation of side effects
e.g- levodopa+carbidopa
 Reduction in number of pills improve the patient compilance.
DEMERITS
• The do of any component cannot be adjusted independently.
• Pharmacokinetics must not be widely different
• It becomes difficult to identify one particular drug which is causing
harmful/beneficial effects.
• Some fixed dose combination show more adverse effect
e.g- nimesulide+pcm
CONT....
• One of the drugs in the combination maybe wasteful
e.g- vitamin+iron
• There willl be increase in price if unnecessary drugs are include.
e.g- ibf+pcm+caffeine
• In FDC there is always a chance that individual medicines may not be
present n adequate amt. e.g- multivitamins
RATIONAL FIXED DOSE
COMBINATION
• Improved patient compilance-simplified disease management for chronic
diseases like HIV,diabetes,hypertension,asthma,etc
• Better efficiacy-synergistic mechanism,improved ADME and drug resistance.
EXAMPLE OF RATIONAL
COMBINATION
• Amoxycillin+clavulanic acid
• Ampicillin+sulbactam
• Ferrous salt+folic acid
• Levodopa+carbidopa
• Lamivudine+zidovudine
• Abacavir+lamivudine+zidovudine
IRRATIONAL THERAPY
RESULT IN-
• Adverse drug reactions
• Emergence of resistant micro-organisms
• Financial complications more costly
• Masking/confusion/delyaing the correct digonsis
REASON FOR IRRATIONAL USE OF
DRUGS
1. Faulty & inadequate training & education of medical graduates
2. Lack of diagonstic facilities/uncertainty of diagonsis
3. Lack of information related to indications & safety of drugs.
4. Poor communication between health professional & patient
CONT..
5.Demand from the patient
6.Promotional activites of pharmaceutical industries
7.Defective drug supply system & infective drug regulation.
HAZARDS OF IRRATIONAL USE OF
DRUGS
• Irrational use of drugs may lead to:
Ineffective & unsafe treatment
Exacerbation or prolongation of illness
Distress & harm to patient
Increase the cost of treatment
EXAMPLES OF IRRATIONAL DRUG
THERAPY
Nimesulide+pcm-
• FDC of analgesi, anti inflammatory and antipyretic results in increased
hepatotoxicity
Ampicillin+cloxacillin-
• ampicillin is effective against Gram negative bacilli but Cloxacillin is an anti-
staphylococcal penicillin and not effective againt Gram -ve and
Staphylococcal(Gram +ve) infection rarely coexists.
CONT..
Gastrointestinal drugs- such as domperidone+rabeprazol increased incidence of
rhabdomyolysis
Anta acid+ antianxiety drug- the acid disease is rearly associated with
pstchosomatic basis so, there is no justification of combining antianxiety drug with
antacid
Metformin+glimepiride+pioglitazone
metformin is indicated drug in obese type-2 diabetes mellitus whereas
Sulfonylurea(glimepiride) is indicated drug in non-obese type-2 diabetes mellitus.
FDC PRODUCTS 1990 TO
2013, CURRENT SITUATION
• For the period 1990 through 2013, the FDA approved a total of 131 prescription FDC products. This
amounts to an average of 5.5 FDC products per year. The peak year for FDA approvals was 2012, with 12
FDC products approved. The low point was 1991 when only a single FDC product was approved. Figure 1
provides a summary of approvals by year.
• Of the 131 approved prescription FDC products approved in this period, a total of 13 have been
discontinued. In some cases, the products were withdrawn because of poor commercial performance, while
in other cases, the products were superseded by improved presentations. Two active FDC products
accounted for 117 of the FDC products, while there were 12 products with three actives and only 2 with
four actives.
• Digging a little deeper, we find that for 21 of the 131 FDC products, the approval of the FDC product was
the first approval for at least one the actives. In one case, Courted (Application Number 22268), the FDC
product approval represented the first approval for both of the actives in the product.
CONCLUSION
• According to the WHO Expert Committee, combination drugs should be
only used when there are no alternative of single drugs available or cost
effective for the purpose.
• Combination drugs increase the risk of side effects and may also needlessly
increase the cost.
• Combination drugs are irrational also because their stability is dpubtful,
reducing the efficacy of many preparations.
THANK YOU

More Related Content

PPTX
Fixed Dose Drug Combination (FDDC)
PPTX
Fixed dose drug combinations
PPTX
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
PPTX
Bioavailability
PPTX
Broad Spectrum Antibiotics.pptx
PPTX
P drug concept
PPTX
Evidence based medicine and tdm
PPTX
Factors modifying drug action
Fixed Dose Drug Combination (FDDC)
Fixed dose drug combinations
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
Bioavailability
Broad Spectrum Antibiotics.pptx
P drug concept
Evidence based medicine and tdm
Factors modifying drug action

What's hot (20)

PPTX
Patient Information Leafelet
PPTX
Adverse drug reaction monitoring and reporting
PPTX
Pharmacoeconomics
PPTX
Patient information leaflets,about disease or drugs,second pharmD ,COMMUNITY ...
PPTX
Clinical pharmacy services
PPTX
Handling and packing of radiopharmaceuticals.
PPTX
Online Pharmacy Views & Counter Views
PPTX
Patient information leaflets
PPTX
Rational drug use
PPTX
Introduction to rational use of drugs and role of pharmacist in rational use...
PPTX
Poison information centre
PPTX
Jan aushadhi scheme ppt
PPT
Role of the pharmacist in medication safety.
PPTX
labelling of dispensed medications.pptx
PPTX
Adverse Drug Reactions
PPTX
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
PPTX
Central Drug Testing Laboratories & Responsibilities
PPTX
Legal requirements
PPT
Medication Related Problems
 
PPTX
I.V ADMIXTURE AND TYPES OF I.V ADMIXTURE
Patient Information Leafelet
Adverse drug reaction monitoring and reporting
Pharmacoeconomics
Patient information leaflets,about disease or drugs,second pharmD ,COMMUNITY ...
Clinical pharmacy services
Handling and packing of radiopharmaceuticals.
Online Pharmacy Views & Counter Views
Patient information leaflets
Rational drug use
Introduction to rational use of drugs and role of pharmacist in rational use...
Poison information centre
Jan aushadhi scheme ppt
Role of the pharmacist in medication safety.
labelling of dispensed medications.pptx
Adverse Drug Reactions
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...
Central Drug Testing Laboratories & Responsibilities
Legal requirements
Medication Related Problems
 
I.V ADMIXTURE AND TYPES OF I.V ADMIXTURE
Ad

Similar to Fixed dose combination (20)

PDF
Rational Fixed dose combination
PDF
Fixed dose combination products – rationality, status in india, development i...
PPTX
FIXED DOSE COMBINATION PHARMACOLOGY.ppt
PDF
Ban of Fixed Dose Combination on India Impact and Implications
PPT
Poster Fdc
PPTX
FIXED DOSE COMBINATIONS BANNED IN INDIA
PPTX
Rational drug, Essential drugs.pptx
PPTX
Pharmacotherapy
PDF
BAN ON FIXED DOSE COMBINATIONS PRODUCTS IN INDIA
PDF
Strategies in Designing Clinicals for Fixed-Combination Drug
PDF
Strategies in Designing Clinicals for Fixed-Combination Drugs
PPTX
Rational Use Anti-infectives CPC rational [Autosaved]_123252.pptx
PPTX
Pharmacotherapy and drug devlopement.pptx
PDF
Pharmacotherapy and drug devlopement.pdf
PPT
Fixed Dose Combinations- WHO Meet
PDF
Nada Alkis' Master Thesis, Novo Nordisk & University of Copenhagen
PPTX
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
PPTX
intro to pharmaceutics-A brief introduction to pharmaceutics first undergradu...
PPTX
A brief introduction to pharmaceutics first undergraduate pharmacy students
PPTX
Nada Alkis' Master Thesis Presentation 16.01.2018
Rational Fixed dose combination
Fixed dose combination products – rationality, status in india, development i...
FIXED DOSE COMBINATION PHARMACOLOGY.ppt
Ban of Fixed Dose Combination on India Impact and Implications
Poster Fdc
FIXED DOSE COMBINATIONS BANNED IN INDIA
Rational drug, Essential drugs.pptx
Pharmacotherapy
BAN ON FIXED DOSE COMBINATIONS PRODUCTS IN INDIA
Strategies in Designing Clinicals for Fixed-Combination Drug
Strategies in Designing Clinicals for Fixed-Combination Drugs
Rational Use Anti-infectives CPC rational [Autosaved]_123252.pptx
Pharmacotherapy and drug devlopement.pptx
Pharmacotherapy and drug devlopement.pdf
Fixed Dose Combinations- WHO Meet
Nada Alkis' Master Thesis, Novo Nordisk & University of Copenhagen
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
intro to pharmaceutics-A brief introduction to pharmaceutics first undergradu...
A brief introduction to pharmaceutics first undergraduate pharmacy students
Nada Alkis' Master Thesis Presentation 16.01.2018
Ad

Recently uploaded (20)

PPTX
preoerative assessment in anesthesia and critical care medicine
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
Post Op complications in general surgery
PPTX
the psycho-oncology for psychiatrists pptx
PPTX
antibiotics rational use of antibiotics.pptx
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPT
Rheumatology Member of Royal College of Physicians.ppt
PPTX
Acid Base Disorders educational power point.pptx
PPTX
Reading between the Rings: Imaging in Brain Infections
PDF
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPTX
Cardiovascular - antihypertensive medical backgrounds
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPTX
Morphology of Bacterial Cell for bsc sud
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
preoerative assessment in anesthesia and critical care medicine
neurology Member of Royal College of Physicians (MRCP).ppt
Copy of OB - Exam #2 Study Guide. pdf
Post Op complications in general surgery
the psycho-oncology for psychiatrists pptx
antibiotics rational use of antibiotics.pptx
PEADIATRICS NOTES.docx lecture notes for medical students
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
Rheumatology Member of Royal College of Physicians.ppt
Acid Base Disorders educational power point.pptx
Reading between the Rings: Imaging in Brain Infections
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
surgery guide for USMLE step 2-part 1.pptx
Cardiovascular - antihypertensive medical backgrounds
MENTAL HEALTH - NOTES.ppt for nursing students
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Morphology of Bacterial Cell for bsc sud
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt

Fixed dose combination

  • 1. FIXED DOSE COMBINATION BY: PRIYA NIGAM M.Sc. Clinical Research
  • 2. DEFINITION OF FDC The combination of two different drugs in a single pharmaceutical formulation is known as fixed drug dose combination. Medicines are an integral part of healthcare. More than one drug is frequently used for treatment of either single ailment or multiple comorbid conditions. Sometimes, two or more drugs are combined in a fixed ratio into a single dosage form, which is termed as fixed dose combinations (FDCs). The FDCs are justified when they demonstrate clear benefits in terms of (a) potentiating the therapeutic efficacy, (b) reducing the incidence of adverse effect of drugs, (c) having pharmacokinetic advantage.
  • 3. Safety and efficacy • There is little question that many patients benefit from receiving more than one pharmaceutical active to treat a medical condition when their actions are synergistic, or at least additive. • Often, efficacy can be significantly improved with minimal impact on the combination product’s safety and tolerability. • The combination of a beta-blocker with a diuretic has a well-established safety and efficacy profile as an antihypertensive. • Raise the dose of the beta-blocker, and you start to have tolerability and safety issues, yet the diuretic alone has limited efficacy by itself. • Put them together, and you have a much better balance of efficacy and safety.
  • 4. AS A RULE • Two drugs to be combined have approxiamately equal plasma half life • The ratio of doses of each component should depend on apparent volume of distribution and plasma concentration. • EXAMPLE: • Amoxycillin(t½ -1-2hr, Vd-0.21L/kg) hence clavulanic acid(t½-1-1.5hr, Vd- 0.2L/kg) hence these can be combined in their standard dose regimen.. i.e amoxycillin 500mg +clavulanic acid 125mg can be administered as 1 to 2 tablet 8 hourly
  • 5. MERITS  Convenience in dose schedule and better patients compiliance.  Enchanced effect of the combination e.g-oestrogen+progestrogene  Minimisation of side effects e.g- levodopa+carbidopa  Reduction in number of pills improve the patient compilance.
  • 6. DEMERITS • The do of any component cannot be adjusted independently. • Pharmacokinetics must not be widely different • It becomes difficult to identify one particular drug which is causing harmful/beneficial effects. • Some fixed dose combination show more adverse effect e.g- nimesulide+pcm
  • 7. CONT.... • One of the drugs in the combination maybe wasteful e.g- vitamin+iron • There willl be increase in price if unnecessary drugs are include. e.g- ibf+pcm+caffeine • In FDC there is always a chance that individual medicines may not be present n adequate amt. e.g- multivitamins
  • 8. RATIONAL FIXED DOSE COMBINATION • Improved patient compilance-simplified disease management for chronic diseases like HIV,diabetes,hypertension,asthma,etc • Better efficiacy-synergistic mechanism,improved ADME and drug resistance.
  • 9. EXAMPLE OF RATIONAL COMBINATION • Amoxycillin+clavulanic acid • Ampicillin+sulbactam • Ferrous salt+folic acid • Levodopa+carbidopa • Lamivudine+zidovudine • Abacavir+lamivudine+zidovudine
  • 10. IRRATIONAL THERAPY RESULT IN- • Adverse drug reactions • Emergence of resistant micro-organisms • Financial complications more costly • Masking/confusion/delyaing the correct digonsis
  • 11. REASON FOR IRRATIONAL USE OF DRUGS 1. Faulty & inadequate training & education of medical graduates 2. Lack of diagonstic facilities/uncertainty of diagonsis 3. Lack of information related to indications & safety of drugs. 4. Poor communication between health professional & patient
  • 12. CONT.. 5.Demand from the patient 6.Promotional activites of pharmaceutical industries 7.Defective drug supply system & infective drug regulation.
  • 13. HAZARDS OF IRRATIONAL USE OF DRUGS • Irrational use of drugs may lead to: Ineffective & unsafe treatment Exacerbation or prolongation of illness Distress & harm to patient Increase the cost of treatment
  • 14. EXAMPLES OF IRRATIONAL DRUG THERAPY Nimesulide+pcm- • FDC of analgesi, anti inflammatory and antipyretic results in increased hepatotoxicity Ampicillin+cloxacillin- • ampicillin is effective against Gram negative bacilli but Cloxacillin is an anti- staphylococcal penicillin and not effective againt Gram -ve and Staphylococcal(Gram +ve) infection rarely coexists.
  • 15. CONT.. Gastrointestinal drugs- such as domperidone+rabeprazol increased incidence of rhabdomyolysis Anta acid+ antianxiety drug- the acid disease is rearly associated with pstchosomatic basis so, there is no justification of combining antianxiety drug with antacid Metformin+glimepiride+pioglitazone metformin is indicated drug in obese type-2 diabetes mellitus whereas Sulfonylurea(glimepiride) is indicated drug in non-obese type-2 diabetes mellitus.
  • 16. FDC PRODUCTS 1990 TO 2013, CURRENT SITUATION • For the period 1990 through 2013, the FDA approved a total of 131 prescription FDC products. This amounts to an average of 5.5 FDC products per year. The peak year for FDA approvals was 2012, with 12 FDC products approved. The low point was 1991 when only a single FDC product was approved. Figure 1 provides a summary of approvals by year. • Of the 131 approved prescription FDC products approved in this period, a total of 13 have been discontinued. In some cases, the products were withdrawn because of poor commercial performance, while in other cases, the products were superseded by improved presentations. Two active FDC products accounted for 117 of the FDC products, while there were 12 products with three actives and only 2 with four actives. • Digging a little deeper, we find that for 21 of the 131 FDC products, the approval of the FDC product was the first approval for at least one the actives. In one case, Courted (Application Number 22268), the FDC product approval represented the first approval for both of the actives in the product.
  • 17. CONCLUSION • According to the WHO Expert Committee, combination drugs should be only used when there are no alternative of single drugs available or cost effective for the purpose. • Combination drugs increase the risk of side effects and may also needlessly increase the cost. • Combination drugs are irrational also because their stability is dpubtful, reducing the efficacy of many preparations.